NCT06468215
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Carcinoma, Endometrioid
Explore clinical trials studying Carcinoma, Endometrioid. Study availability and eligibility vary by location and protocol.
19 public trials
7 recruiting studies
Carcinoma, Endometrioid trial results
NCT05112601
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University Cancer and Blood Center LLC Athens, Georgia, United States
- Augusta University Medical Center Augusta, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise Boise, Idaho, United States
Recruiting
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
NCT06549855
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +23 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT04291612
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +22 more
- Locations
-
- Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
- Miami Cancer Institute Baptist Health South Florida Miami, Florida, United States
- ADVENTHEALTH (Data collection only) Orlando, Florida, United States
- Mayo Clinic (Data Collection and Data Analysis) Rochester, Minnesota, United States
NCT06463028
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +31 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California, San Francisco (UCSF) San Francisco, California, United States
- Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
- Florida Cancer Specialists, North St. Petersburg, Florida, United States
NCT05080556
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University College London Hospitals London, United Kingdom
NCT05945407
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +22 more
- Locations
-
- Peking University People's Hosoital Beijing, Beijing Municipality, China
NCT03660826
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, not recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, not recruiting
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.
NCT02598219
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +20 more
- Locations
-
- Polyclinique Urbain V Avignon, France
- Centre Hospitalier Régional Universitaire Besançon, France
- Institut Bergonié Bordeaux, France
- Centre Jean Perrin Clermont-Ferrand, France